The x-factor involved in apoptosis and proliferation—reciprocal exosome cross-talk between lymphangioleiomyomatosis-derived smooth muscle cells (LAM-SMCs) and endothelial cells (ECs) mediates EC network disruption/apoptosis and promotes LAM-SMC growth

      Introduction: Lymphangioleiomyomatosis (LAM) is a progressive and incurable disease caused by mutations in the TSC2 gene, which is involved in mTOR pathway regulation. Fragile endothelial cell (EC) neovessels are stabilized by mural smooth muscle cells (SMCs). However, SMC-like LAM cells invade and destroy the lung through unknown mechanism(s). We postulate that LAM-SMCs will disrupt EC capillary-like networks and promote EC apoptosis.
      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'


      Subscribe to Cytotherapy
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect